阿尔多激素合成酶抑制剂的降血压效果-系统性审查
Anders Almskou Rasmussen1, Ketil Lehm Nordestgaard1, Ulf Simonsen1
1Department of Biomedicine, HEALTH, Aarhus University, Aarhus, Denmark.
Basic & clinical pharmacology & toxicology
|July 22, 2025
概括
阿尔多氨酸合成酶抑制剂 (ASIs) 在高血压患者中有效降低血压. 这些药物显示出有希望的脏保护作用,对皮质醇水平的影响最小,尽管心血管结果需要进一步研究.
科学领域:
- 内分泌学和脏学.
- 心血管医学 心血管医学
背景情况:
- 过度的阿尔多素生产是高血压的关键驱动因素,导致心脏,血管和脏的目标器官受损.
- 针对阿尔多激素合成的新药的开发对于管理高血压及其并发症至关重要.
研究的目的:
- 系统地审查ASIs在高血压患者中降低血压的影响.
- 评估ASI的潜在脏保护作用.
- 评估ASI对皮质醇产生和血度的影响.
主要方法:
- 随机对照试验和临床试验的系统审查和元分析.
- 在PubMed,Embase和ClinicalTrials.gov.gov进行的搜索.
- 使用基于PICO标准的Covidence审查工具提取和分析数据.
主要成果:
- 所有13项包括在内的研究都表明,随着ASI治疗,血压显著降低.
- 与安慰剂纠正的缩血压降低在耐药高血压的特定ASI中从9.6到11.0mmHg不等.
- 一些ASI抑制了皮质醇的产生,而另一些则表现出脏保护作用 (尿中白蛋白-肌素比率降低).
- 附加感染可能导致水平升高.
结论:
- 阿尔多氨酸合成酶抑制剂 (ASIs) 在高血压患者中表现出显著的降血压效应.
- ASI显示出有前途的脏保护作用,特别是在慢性脏疾病中,对皮质醇的产生影响有限.
- 需要进一步的研究来评估ASIs对高血压目标器官损伤和心血管结果的长期影响.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
830
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
830
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
928
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
928
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
891
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
891
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
774
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
774
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
511
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
511
01:17Antihypertensive Drugs: Action of β1 Blockers
613
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
613